MODAKAFUSP ALFA
UNII TN8CEX4UT2

Substance Identification & Data

This profile provides standardized clinical and technical data for Modakafusp Alfa, uniquely identified by the FDA Unique Ingredient Identifier (UNII) TN8CEX4UT2.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2254522-19-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

TN8CEX4UT2

CAS Registry Number

2254522-19-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

MODAKAFUSP ALFA

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C140427

National Cancer Institute reference terminology for clinical and research data.

INN ID

11306

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

JK-216

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Modakafusp Alfa. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

MODAKAFUSP ALFA

Common Names & Synonyms

ANTI-CD38-TARGETED IGG4-ATTENUATED IFNA TAK-573

MODAKAFUSP ALFA [INN]

MODAKAFUSP ALFA [USAN]

MODAKAFUSP ALFA [WHO-DD]

Systematic Nomenclature

IMMUNOGLOBULIN G4 (228-PROLINE), ANTI-(HUMAN ANTIGEN CD38) (HUMAN-RATTUS NORVEGICUS MONOCLONAL TAK-573 .GAMMA.4-CHAIN) FC C-TERMINAL FUSION PROTEIN WITH HUMAN INTERFERON .ALPHA.2B (106-ALANINE,145-ASPARTIC ACID), DISULFIDE WITH HUMAN-RATTUS NORVEGICUS MONOCLONAL TAK-573 .KAPPA.-CHAIN, DIMER

SYS